Cochrane Review Group
Pregnancy and Childbirth
252 systematic reviews in Pregnancy and Childbirth ask 3,601 questions. 20.2% have no studies to answer them, 23% rest on very low certainty evidence and 17.6% reach moderate or high certainty.
Reviews
252
Questions
3,601
current versions
No studies
20.2%
Moderate or high
17.6%
No studies 726 · 20.2%Ungraded 421 · 11.7%Very low 828 · 23%Low 993 · 27.6%Moderate 486 · 13.5%High 147 · 4.1%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Magnesium sulphate vs placebo (outcomes Major neurodevelopmental disability (school age)** · women at risk of preterm birth (< 34 weeks' gestation) Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus (2024) · Cochrane | RR 0.92 [0.53, 1.62] | 2 studies · 940 participants | Very low |
Magnesium sulphate vs placebo (outcomes Breastfeeding at hospital discharge** · women at risk of preterm birth (< 34 weeks' gestation) Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus (2024) · Cochrane | no estimate extracted | NR | No studies |
Magnesium sulphate vs placebo (outcomes Women’s views of treatment** · women at risk of preterm birth (< 34 weeks' gestation) Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Midwife continuity models vs other models of care Third or fourth degree tear · childbearing women and their infants (all) (important/secondary outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 1.1 [0.81, 1.49] | 7 studies · 9437 participants | Very low |
Summary of findings table ‐ Midwife continuity models vs other models of care Maternal readmission within 28 days · childbearing women and their infants (all) (important/secondary outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 1.52 [0.78, 2.96] | 1 study · 1195 participants | Very low |
Summary of findings table ‐ Midwife continuity models vs other models of care Attendance at birth by known midwife · childbearing women and their infants (all) (important/secondary outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 9.13 [5.87, 14.21] | 11 studies · 9273 participants | Very low |
Summary of findings table ‐ Midwife continuity models vs other models of care Apgar score less than or equal to 7 at 5 minutes · childbearing women and their infants (all) (important/secondary outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 0.95 [0.72, 1.24] | 13 studies · 12806 participants | Very low |
Summary of findings table ‐ Midwife continuity models vs other models of care Fetal loss before 24 weeks gestation · childbearing women and their infants (all) (important/secondary outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 0.82 [0.67, 1.01] | 12 studies · 15913 participants | Very low |
Summary of findings table ‐ Midwife continuity of care models vs other models of care Regional analgesia (epidural/spinal) · childbearing women and their infants (all) (critical outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 0.85 [0.79, 0.92] | 15 studies · 17754 participants | Very low |
Summary of findings table ‐ Midwife continuity of care models vs other models of care Fetal loss at or after 24 weeks gestation · childbearing women and their infants (all) (critical outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 1.24 [0.73, 2.13] | 12 studies · 16122 participants | Very low |
Summary of findings table ‐ Midwife continuity of care models vs other models of care Neonatal death (baby born alive at any gestation and dies within 28 days) · childbearing women and their infants (all) (critical outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 0.85 [0.43, 1.71] | 10 studies · 14718 participants | Very low |
Summary of findings table ‐ Vitamin B12 supplementation vs placebo/no vitamin B12 supplementation Maternal anaemia · pregnant women Vitamin B12 supplementation during pregnancy for maternal and child health outcomes (2024) · Cochrane | RR 1.08 [0.93, 1.26] | 2 studies · 284 participants | Very low |
Reviews 252
Dietary supplementation with myo‐inositol in women during pregnancy for treating gestational diabetes
CochraneSoF table
14 questions
Anti‐D administration in pregnancy for preventing Rhesus alloimmunisation
CochraneSoF table
7 questions
Antenatal dietary education and supplementation to increase energy and protein intake
CochraneSoF table
28 questions
External cephalic version for breech presentation at term
CochraneSoF table
6 questions
External cephalic version for breech presentation before term
CochraneSoF table
7 questions
Fetal electrocardiogram (ECG) for fetal monitoring during labour
CochraneSoF table
7 questions
Planned caesarean section for term breech delivery
CochraneSoF table
7 questions
Pyridoxine (vitamin B6) supplementation during pregnancy or labour for maternal and neonatal outcomes
CochraneSoF table
7 questions
Interventions for helping to turn term breech babies to head first presentation when using external cephalic version
CochraneSoF table
14 questions
Duration of treatment for asymptomatic bacteriuria during pregnancy
CochraneSoF table
8 questions
Alternative versus standard packages of antenatal care for low‐risk pregnancy
CochraneSoF table
6 questions
Interventions for varicose veins and leg oedema in pregnancy
CochraneSoF table
6 questions
Antibiotic regimens for postpartum endometritis
CochraneSoF table
8 questions
Interventions for preventing and treating low‐back and pelvic pain during pregnancy
CochraneSoF table
4 questions
Fetal and umbilical Doppler ultrasound in normal pregnancy
CochraneSoF table
7 questions
Routine ultrasound in late pregnancy (after 24 weeks' gestation)
CochraneSoF table
7 questions
Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity
CochraneSoF table
6 questions
Giving women their own case notes to carry during pregnancy
CochraneSoF table
7 questions
Vaccines for women for preventing neonatal tetanus
CochraneSoF table
14 questions
Vitamin E supplementation in pregnancy
CochraneSoF table
6 questions
Vitamin C supplementation in pregnancy
CochraneSoF table
6 questions
Prophylactic oral betamimetics for reducing preterm birth in women with a twin pregnancy
CochraneSoF table
4 questions
Daily oral iron supplementation during pregnancy
CochraneSoF table
22 questions
Pneumococcal vaccination during pregnancy for preventing infant infection
CochraneSoF table
7 questions
Fetal movement counting for assessment of fetal wellbeing
CochraneSoF table
7 questions